Innovative Drying Technologies for Biopharmaceuticals ...
(Dry powder for oral inhalation against influenza like illness) (Bodier-Montagutelli et al., 2018, ECRI, 2011, Mack et al., 2012, Moss and Li, 2015) CSJ117 by Novartis (Clinical Trial Phase 2) Anti-TSLP antibody fragment. Leucine, trileucine, mannitol and trehalose. PulmoSol TM engineered powder. (Dry powder inhaled for asthma).
Get Price